Urinary levels of molecules associated with renal ischemia (VEGF and MCP-1) or tubular injury (β2MG) were correlated with deteriorating renal function in ADPKD patients, thus suggesting their potential as biomarkers for monitoring disease progression (73). Here, VEGFA is linked to autosomal dominant polycystic kidney disease.